Thomaidis, T., & Hofheinz, R. (2014). VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: A comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BMC cancer, 14, . https://doi.org/10.1186/1471-2407-14-476
Chicago-Zitierstil (17. Ausg.)Thomaidis, Thomas, und Ralf-Dieter Hofheinz. "VEGFR-3 and CXCR4 as Predictive Markers for Treatment with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin in Patients with Advanced Esophagogastric Cancer: A Comparative Study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)." BMC Cancer 14 (2014). https://doi.org/10.1186/1471-2407-14-476.
MLA-Zitierstil (9. Ausg.)Thomaidis, Thomas, und Ralf-Dieter Hofheinz. "VEGFR-3 and CXCR4 as Predictive Markers for Treatment with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin in Patients with Advanced Esophagogastric Cancer: A Comparative Study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)." BMC Cancer, vol. 14, 2014, https://doi.org/10.1186/1471-2407-14-476.